Facebook
Twitter
LinkedIn
ForwardSponsored Session: Host Response Diagnostics: Evolving the Standard of Care for Acute Infection and Sepsis in the ED
Session Description:
Sponsored by Inflammatix
In this sponsored session, learners will review the immune response to infection and how to measure that response in the ED, with an emphasis on the Inflammatix Host Response approach, which measures immune gene expression in response to pathogens. This diagnostic approach was developed to address unmet needs in diagnosis and treatment of acute infection and sepsis in the ED, which the presenter will review. The presenter will also describe how multicohort analysis and machine learning can be used to develop clinically robust tests with broad applications for the diagnosis and treatment of disease, and how all of this can be done at the point of care.
This session was originally recorded in September 2022 as part of Sepsis Alliance Summit.
Target Audience
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Sepsis Alliance gratefully acknowledges the support provided for this session by Inflammatix.
Tim Sweeney, MD, PhD
Co-Founder and Chief Executive Officer, Inflammatix
Tim Sweeney, MD, PhD, helped invent the core Inflammatix technology and is a licensed physician and data scientist. He completed his MD/PhD at Duke University and then spent time training in the general surgery residency program at Stanford University. While training as a surgeon, he became frustrated with the current diagnostic tools for infection. During his residency research years, he completed a postdoc MS in Biomedical Informatics, during which he worked with Dr. Khatri to identify a new way to diagnose infections based on ‘reading’ the immune system. Their work designing custom informatics algorithms for sifting through heterogeneous large datasets led to the core technology on which Inflammatix is based.
No continuing education credits are offered for this session. Content is provided by the sponsor.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.